0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Procalcitonin Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19M9390
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Procalcitonin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Procalcitonin Market Research Report 2025

Code: QYRE-Auto-19M9390
Report
May 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Procalcitonin Market Size

The global market for Procalcitonin was valued at US$ 82.8 million in the year 2024 and is projected to reach a revised size of US$ 135 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Procalcitonin Market

Procalcitonin Market

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Procalcitonin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin.
The Procalcitonin market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Procalcitonin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Procalcitonin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Procalcitonin Market Report

Report Metric Details
Report Name Procalcitonin Market
Accounted market size in year US$ 82.8 million
Forecasted market size in 2031 US$ 135 million
CAGR 7.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Medical Industry
  • Scientific Research
  • Veterinarian
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Procalcitonin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Procalcitonin Market growing?

Ans: The Procalcitonin Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Procalcitonin Market size in 2031?

Ans: The Procalcitonin Market size in 2031 will be US$ 135 million.

What is the market share of major companies in Procalcitonin Market?

Ans: Global top five manufacturers hold a share about 35%.

What is the Procalcitonin Market share by type?

Ans: In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%.

Who are the main players in the Procalcitonin Market report?

Ans: The main players in the Procalcitonin Market are Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis

What are the Application segmentation covered in the Procalcitonin Market report?

Ans: The Applications covered in the Procalcitonin Market report are Medical Industry, Scientific Research, Veterinarian

What are the Type segmentation covered in the Procalcitonin Market report?

Ans: The Types covered in the Procalcitonin Market report are Procalcitonin Antigen, Procalcitonin Antibody

Recommended Reports

Peptide Therapeutics

Diagnostic Testing

Clinical Diagnostics

1 Procalcitonin Market Overview
1.1 Product Definition
1.2 Procalcitonin by Type
1.2.1 Global Procalcitonin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin by Application
1.3.1 Global Procalcitonin Market Value by Application (2024 VS 2031)
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Global Procalcitonin Market Size Estimates and Forecasts
1.4.1 Global Procalcitonin Revenue 2020-2031
1.4.2 Global Procalcitonin Sales 2020-2031
1.4.3 Global Procalcitonin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Procalcitonin Market Competition by Manufacturers
2.1 Global Procalcitonin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Procalcitonin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Procalcitonin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Procalcitonin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Procalcitonin, Product Type & Application
2.7 Global Key Manufacturers of Procalcitonin, Date of Enter into This Industry
2.8 Global Procalcitonin Market Competitive Situation and Trends
2.8.1 Global Procalcitonin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Procalcitonin Players Market Share by Revenue
2.8.3 Global Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Procalcitonin Market Scenario by Region
3.1 Global Procalcitonin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Procalcitonin Sales by Region: 2020-2031
3.2.1 Global Procalcitonin Sales by Region: 2020-2025
3.2.2 Global Procalcitonin Sales by Region: 2026-2031
3.3 Global Procalcitonin Revenue by Region: 2020-2031
3.3.1 Global Procalcitonin Revenue by Region: 2020-2025
3.3.2 Global Procalcitonin Revenue by Region: 2026-2031
3.4 North America Procalcitonin Market Facts & Figures by Country
3.4.1 North America Procalcitonin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Procalcitonin Sales by Country (2020-2031)
3.4.3 North America Procalcitonin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Procalcitonin Market Facts & Figures by Country
3.5.1 Europe Procalcitonin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Procalcitonin Sales by Country (2020-2031)
3.5.3 Europe Procalcitonin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Procalcitonin Market Facts & Figures by Region
3.6.1 Asia Pacific Procalcitonin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Procalcitonin Sales by Region (2020-2031)
3.6.3 Asia Pacific Procalcitonin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Procalcitonin Market Facts & Figures by Country
3.7.1 Latin America Procalcitonin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Procalcitonin Sales by Country (2020-2031)
3.7.3 Latin America Procalcitonin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Procalcitonin Market Facts & Figures by Country
3.8.1 Middle East and Africa Procalcitonin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Procalcitonin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Procalcitonin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Procalcitonin Sales by Type (2020-2031)
4.1.1 Global Procalcitonin Sales by Type (2020-2025)
4.1.2 Global Procalcitonin Sales by Type (2026-2031)
4.1.3 Global Procalcitonin Sales Market Share by Type (2020-2031)
4.2 Global Procalcitonin Revenue by Type (2020-2031)
4.2.1 Global Procalcitonin Revenue by Type (2020-2025)
4.2.2 Global Procalcitonin Revenue by Type (2026-2031)
4.2.3 Global Procalcitonin Revenue Market Share by Type (2020-2031)
4.3 Global Procalcitonin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Procalcitonin Sales by Application (2020-2031)
5.1.1 Global Procalcitonin Sales by Application (2020-2025)
5.1.2 Global Procalcitonin Sales by Application (2026-2031)
5.1.3 Global Procalcitonin Sales Market Share by Application (2020-2031)
5.2 Global Procalcitonin Revenue by Application (2020-2031)
5.2.1 Global Procalcitonin Revenue by Application (2020-2025)
5.2.2 Global Procalcitonin Revenue by Application (2026-2031)
5.2.3 Global Procalcitonin Revenue Market Share by Application (2020-2031)
5.3 Global Procalcitonin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Procalcitonin Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Company Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Diagnostics Procalcitonin Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 bioMerieux
6.3.1 bioMerieux Company Information
6.3.2 bioMerieux Description and Business Overview
6.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 bioMerieux Procalcitonin Product Portfolio
6.3.5 bioMerieux Recent Developments/Updates
6.4 HyTest
6.4.1 HyTest Company Information
6.4.2 HyTest Description and Business Overview
6.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 HyTest Procalcitonin Product Portfolio
6.4.5 HyTest Recent Developments/Updates
6.5 BBI Solutions
6.5.1 BBI Solutions Company Information
6.5.2 BBI Solutions Description and Business Overview
6.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BBI Solutions Procalcitonin Product Portfolio
6.5.5 BBI Solutions Recent Developments/Updates
6.6 ProSpec
6.6.1 ProSpec Company Information
6.6.2 ProSpec Description and Business Overview
6.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ProSpec Procalcitonin Product Portfolio
6.6.5 ProSpec Recent Developments/Updates
6.7 Wondfo
6.7.1 Wondfo Company Information
6.7.2 Wondfo Description and Business Overview
6.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Wondfo Procalcitonin Product Portfolio
6.7.5 Wondfo Recent Developments/Updates
6.8 Ningbo Medicalsystem Biotechnology
6.8.1 Ningbo Medicalsystem Biotechnology Company Information
6.8.2 Ningbo Medicalsystem Biotechnology Description and Business Overview
6.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
6.8.5 Ningbo Medicalsystem Biotechnology Recent Developments/Updates
6.9 Wuhan Easy Diagnosis Biomedicine
6.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
6.9.2 Wuhan Easy Diagnosis Biomedicine Description and Business Overview
6.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
6.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
6.10 Snibe
6.10.1 Snibe Company Information
6.10.2 Snibe Description and Business Overview
6.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Snibe Procalcitonin Product Portfolio
6.10.5 Snibe Recent Developments/Updates
6.11 Vazyme Biotech
6.11.1 Vazyme Biotech Company Information
6.11.2 Vazyme Biotech Description and Business Overview
6.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vazyme Biotech Procalcitonin Product Portfolio
6.11.5 Vazyme Biotech Recent Developments/Updates
6.12 Getein Biotech
6.12.1 Getein Biotech Company Information
6.12.2 Getein Biotech Description and Business Overview
6.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Getein Biotech Procalcitonin Product Portfolio
6.12.5 Getein Biotech Recent Developments/Updates
6.13 Hotgen Biotech
6.13.1 Hotgen Biotech Company Information
6.13.2 Hotgen Biotech Description and Business Overview
6.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hotgen Biotech Procalcitonin Product Portfolio
6.13.5 Hotgen Biotech Recent Developments/Updates
6.14 Lumigenex
6.14.1 Lumigenex Company Information
6.14.2 Lumigenex Description and Business Overview
6.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lumigenex Procalcitonin Product Portfolio
6.14.5 Lumigenex Recent Developments/Updates
6.15 Nanjing Norman Biological Technology
6.15.1 Nanjing Norman Biological Technology Company Information
6.15.2 Nanjing Norman Biological Technology Description and Business Overview
6.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
6.15.5 Nanjing Norman Biological Technology Recent Developments/Updates
6.16 Kitgen
6.16.1 Kitgen Company Information
6.16.2 Kitgen Description and Business Overview
6.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Kitgen Procalcitonin Product Portfolio
6.16.5 Kitgen Recent Developments/Updates
6.17 Beijing KeyGen
6.17.1 Beijing KeyGen Company Information
6.17.2 Beijing KeyGen Description and Business Overview
6.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Beijing KeyGen Procalcitonin Product Portfolio
6.17.5 Beijing KeyGen Recent Developments/Updates
6.18 Beijing Apis
6.18.1 Beijing Apis Company Information
6.18.2 Beijing Apis Description and Business Overview
6.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Apis Procalcitonin Product Portfolio
6.18.5 Beijing Apis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Procalcitonin Industry Chain Analysis
7.2 Procalcitonin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Procalcitonin Production Mode & Process Analysis
7.4 Procalcitonin Sales and Marketing
7.4.1 Procalcitonin Sales Channels
7.4.2 Procalcitonin Distributors
7.5 Procalcitonin Customer Analysis
8 Procalcitonin Market Dynamics
8.1 Procalcitonin Industry Trends
8.2 Procalcitonin Market Drivers
8.3 Procalcitonin Market Challenges
8.4 Procalcitonin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Procalcitonin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Procalcitonin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Procalcitonin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Procalcitonin Sales (mg) of Key Manufacturers (2020-2025)
 Table 5. Global Procalcitonin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Procalcitonin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Procalcitonin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Procalcitonin Average Price (USD/mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Procalcitonin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Procalcitonin, Product Type & Application
 Table 12. Global Key Manufacturers of Procalcitonin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Procalcitonin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procalcitonin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Procalcitonin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Procalcitonin Sales by Region (2020-2025) & (mg)
 Table 18. Global Procalcitonin Sales Market Share by Region (2020-2025)
 Table 19. Global Procalcitonin Sales by Region (2026-2031) & (mg)
 Table 20. Global Procalcitonin Sales Market Share by Region (2026-2031)
 Table 21. Global Procalcitonin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Procalcitonin Revenue Market Share by Region (2020-2025)
 Table 23. Global Procalcitonin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Procalcitonin Revenue Market Share by Region (2026-2031)
 Table 25. North America Procalcitonin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Procalcitonin Sales by Country (2020-2025) & (mg)
 Table 27. North America Procalcitonin Sales by Country (2026-2031) & (mg)
 Table 28. North America Procalcitonin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Procalcitonin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Procalcitonin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Procalcitonin Sales by Country (2020-2025) & (mg)
 Table 32. Europe Procalcitonin Sales by Country (2026-2031) & (mg)
 Table 33. Europe Procalcitonin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Procalcitonin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Procalcitonin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Procalcitonin Sales by Region (2020-2025) & (mg)
 Table 37. Asia Pacific Procalcitonin Sales by Region (2026-2031) & (mg)
 Table 38. Asia Pacific Procalcitonin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Procalcitonin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Procalcitonin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Procalcitonin Sales by Country (2020-2025) & (mg)
 Table 42. Latin America Procalcitonin Sales by Country (2026-2031) & (mg)
 Table 43. Latin America Procalcitonin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Procalcitonin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Procalcitonin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Procalcitonin Sales by Country (2020-2025) & (mg)
 Table 47. Middle East and Africa Procalcitonin Sales by Country (2026-2031) & (mg)
 Table 48. Middle East and Africa Procalcitonin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Procalcitonin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Procalcitonin Sales (mg) by Type (2020-2025)
 Table 51. Global Procalcitonin Sales (mg) by Type (2026-2031)
 Table 52. Global Procalcitonin Sales Market Share by Type (2020-2025)
 Table 53. Global Procalcitonin Sales Market Share by Type (2026-2031)
 Table 54. Global Procalcitonin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Procalcitonin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Procalcitonin Revenue Market Share by Type (2020-2025)
 Table 57. Global Procalcitonin Revenue Market Share by Type (2026-2031)
 Table 58. Global Procalcitonin Price (USD/mg) by Type (2020-2025)
 Table 59. Global Procalcitonin Price (USD/mg) by Type (2026-2031)
 Table 60. Global Procalcitonin Sales (mg) by Application (2020-2025)
 Table 61. Global Procalcitonin Sales (mg) by Application (2026-2031)
 Table 62. Global Procalcitonin Sales Market Share by Application (2020-2025)
 Table 63. Global Procalcitonin Sales Market Share by Application (2026-2031)
 Table 64. Global Procalcitonin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Procalcitonin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Procalcitonin Revenue Market Share by Application (2020-2025)
 Table 67. Global Procalcitonin Revenue Market Share by Application (2026-2031)
 Table 68. Global Procalcitonin Price (USD/mg) by Application (2020-2025)
 Table 69. Global Procalcitonin Price (USD/mg) by Application (2026-2031)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher Procalcitonin Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. Roche Diagnostics Company Information
 Table 76. Roche Diagnostics Description and Business Overview
 Table 77. Roche Diagnostics Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 78. Roche Diagnostics Procalcitonin Product
 Table 79. Roche Diagnostics Recent Developments/Updates
 Table 80. bioMerieux Company Information
 Table 81. bioMerieux Description and Business Overview
 Table 82. bioMerieux Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 83. bioMerieux Procalcitonin Product
 Table 84. bioMerieux Recent Developments/Updates
 Table 85. HyTest Company Information
 Table 86. HyTest Description and Business Overview
 Table 87. HyTest Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 88. HyTest Procalcitonin Product
 Table 89. HyTest Recent Developments/Updates
 Table 90. BBI Solutions Company Information
 Table 91. BBI Solutions Description and Business Overview
 Table 92. BBI Solutions Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 93. BBI Solutions Procalcitonin Product
 Table 94. BBI Solutions Recent Developments/Updates
 Table 95. ProSpec Company Information
 Table 96. ProSpec Description and Business Overview
 Table 97. ProSpec Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 98. ProSpec Procalcitonin Product
 Table 99. ProSpec Recent Developments/Updates
 Table 100. Wondfo Company Information
 Table 101. Wondfo Description and Business Overview
 Table 102. Wondfo Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 103. Wondfo Procalcitonin Product
 Table 104. Wondfo Recent Developments/Updates
 Table 105. Ningbo Medicalsystem Biotechnology Company Information
 Table 106. Ningbo Medicalsystem Biotechnology Description and Business Overview
 Table 107. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 108. Ningbo Medicalsystem Biotechnology Procalcitonin Product
 Table 109. Ningbo Medicalsystem Biotechnology Recent Developments/Updates
 Table 110. Wuhan Easy Diagnosis Biomedicine Company Information
 Table 111. Wuhan Easy Diagnosis Biomedicine Description and Business Overview
 Table 112. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 113. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product
 Table 114. Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
 Table 115. Snibe Company Information
 Table 116. Snibe Description and Business Overview
 Table 117. Snibe Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 118. Snibe Procalcitonin Product
 Table 119. Snibe Recent Developments/Updates
 Table 120. Vazyme Biotech Company Information
 Table 121. Vazyme Biotech Description and Business Overview
 Table 122. Vazyme Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 123. Vazyme Biotech Procalcitonin Product
 Table 124. Vazyme Biotech Recent Developments/Updates
 Table 125. Getein Biotech Company Information
 Table 126. Getein Biotech Description and Business Overview
 Table 127. Getein Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 128. Getein Biotech Procalcitonin Product
 Table 129. Getein Biotech Recent Developments/Updates
 Table 130. Hotgen Biotech Company Information
 Table 131. Hotgen Biotech Description and Business Overview
 Table 132. Hotgen Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 133. Hotgen Biotech Procalcitonin Product
 Table 134. Hotgen Biotech Recent Developments/Updates
 Table 135. Lumigenex Company Information
 Table 136. Lumigenex Description and Business Overview
 Table 137. Lumigenex Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 138. Lumigenex Procalcitonin Product
 Table 139. Lumigenex Recent Developments/Updates
 Table 140. Nanjing Norman Biological Technology Company Information
 Table 141. Nanjing Norman Biological Technology Description and Business Overview
 Table 142. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 143. Nanjing Norman Biological Technology Procalcitonin Product
 Table 144. Nanjing Norman Biological Technology Recent Developments/Updates
 Table 145. Kitgen Company Information
 Table 146. Kitgen Description and Business Overview
 Table 147. Kitgen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 148. Kitgen Procalcitonin Product
 Table 149. Kitgen Recent Developments/Updates
 Table 150. Beijing KeyGen Company Information
 Table 151. Beijing KeyGen Description and Business Overview
 Table 152. Beijing KeyGen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 153. Beijing KeyGen Procalcitonin Product
 Table 154. Beijing KeyGen Recent Developments/Updates
 Table 155. Beijing Apis Company Information
 Table 156. Beijing Apis Description and Business Overview
 Table 157. Beijing Apis Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 158. Beijing Apis Procalcitonin Product
 Table 159. Beijing Apis Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Procalcitonin Distributors List
 Table 163. Procalcitonin Customers List
 Table 164. Procalcitonin Market Trends
 Table 165. Procalcitonin Market Drivers
 Table 166. Procalcitonin Market Challenges
 Table 167. Procalcitonin Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Procalcitonin
 Figure 2. Global Procalcitonin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Procalcitonin Market Share by Type: 2024 & 2031
 Figure 4. Procalcitonin Antigen Product Picture
 Figure 5. Procalcitonin Antibody Product Picture
 Figure 6. Global Procalcitonin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Procalcitonin Market Share by Application: 2024 & 2031
 Figure 8. Medical Industry
 Figure 9. Scientific Research
 Figure 10. Veterinarian
 Figure 11. Global Procalcitonin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Procalcitonin Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Procalcitonin Sales (2020-2031) & (mg)
 Figure 14. Global Procalcitonin Average Price (USD/mg) & (2020-2031)
 Figure 15. Procalcitonin Report Years Considered
 Figure 16. Procalcitonin Sales Share by Manufacturers in 2024
 Figure 17. Global Procalcitonin Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Procalcitonin Players: Market Share by Revenue in Procalcitonin in 2024
 Figure 19. Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Procalcitonin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Procalcitonin Sales Market Share by Country (2020-2031)
 Figure 22. North America Procalcitonin Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Procalcitonin Sales Market Share by Country (2020-2031)
 Figure 26. Europe Procalcitonin Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Procalcitonin Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Procalcitonin Revenue Market Share by Region (2020-2031)
 Figure 34. China Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Procalcitonin Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Procalcitonin Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Procalcitonin Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Procalcitonin Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Procalcitonin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Procalcitonin by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Procalcitonin by Type (2020-2031)
 Figure 56. Global Procalcitonin Price (USD/mg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Procalcitonin by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Procalcitonin by Application (2020-2031)
 Figure 59. Global Procalcitonin Price (USD/mg) by Application (2020-2031)
 Figure 60. Procalcitonin Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart